Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Magainin Pharmaceuticals Inc.

Magainin Pharmaceuticals Inc. is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Research and development efforts in anti-angiogenesis, obesity, infectious diseases and respiratory diseases.


Contact Details:
5110 Campus Drive
Plymouth Meeting
Pennsylvania
19462
United States of America
Tel:(610) 941-4020
Fax:(610) 941-5399
Email:info@magainin.com
WWW:

www.magainin.com/




Loading...

BioNews Results for Magainin Pharmaceuticals Inc.:

Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
Pharma Live:  Nov 23 2009 2:24AM Matching: pharmaceuticals inc
Analyst Choice Brings New Analysis on Level 3 Communications Inc., Arris Group Inc., Virgin Media Inc., The South Financial Group Inc., Wynn Resorts Limited and AMAG Pharmaceuticals Inc.
Individual.com:  Nov 21 2009 6:41AM Matching: pharmaceuticals inc
Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
RBC Dain Rauscher:  Nov 21 2009 12:46AM Matching: pharmaceuticals inc
FDA approves sNDA for pediatric autism drug ABILIFY
News-Medical.Net:  Nov 21 2009 4:57AM Matching: pharmaceuticals inc
Global market for anti-depressants on a decline
News-Medical.Net:  Nov 20 2009 11:09AM Matching: pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Magainin Pharmaceuticals Inc. news.

Magainin Pharmaceuticals Inc. Patents:

US Patent No.Title
6610866 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
5734015 Family of linear antimicrobial peptides from hagfish intestine
5733899 Method for treating infection using steroid based pharmaceutical compositions
5721226 Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives
5686563 Biologically active peptides having n-terminal substitutions

View more Magainin Pharmaceuticals Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 498 times since April 2007, the link to the organisation's website has been followed 107 times

Recent Search Terms used to find this page: Magainin Pharmaceuticals Inc. | magainin pharmaceuticals | magainin pharmaceuticals | Magainin Pharmaceuticals Inc | Magainin Pharmaceuticals Inc. | magainin pharmaceuticals | magainin | magainin pharmaceuticals approval | Magainin Pharmaceuticals | Magainin Pharmaceuticals Inc. | .

Search for more companies in Plymouth Meeting

Search for more companies in Pennsylvania



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Magainin Pharmaceuticals Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.